🇵🇹 O Podcast onde os temas da Tecnologia e Saúde se cruzam para criar um espaço de debate aberto e inovador, através de entrevistas descontraídas, mas com conteúdos importantes e atuais. Ambicionamos que este podcast sirva como fonte de inovação e de criatividade para os nossos ouvintes.
🇺🇸 🇬🇧 The Cruzamento Podcast is where Technology and Health intersect to create an open and innovative debate, through relevant, current and informal interviews with recognised thought leaders. Our ambition is that this podcast becomes a source of innovation and creativity for all our listeners.
All content for Podcast Cruzamento is the property of André Correia e Daniel Guedelha and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
🇵🇹 O Podcast onde os temas da Tecnologia e Saúde se cruzam para criar um espaço de debate aberto e inovador, através de entrevistas descontraídas, mas com conteúdos importantes e atuais. Ambicionamos que este podcast sirva como fonte de inovação e de criatividade para os nossos ouvintes.
🇺🇸 🇬🇧 The Cruzamento Podcast is where Technology and Health intersect to create an open and innovative debate, through relevant, current and informal interviews with recognised thought leaders. Our ambition is that this podcast becomes a source of innovation and creativity for all our listeners.
In today's episode of CRUZAMENTO Podcast, hosts André Correia and Daniel Guedelha sit down with biotech entrepreneur Nuno Prego Ramos to explore the intersection of technology and healthcare. Nuno shares insights into his groundbreaking work at Cellmabs, a biotech company focusing on cancer-specific antigens, and its landmark deal with BioNTech. He also introduces Valvian, his new venture targeting age-related diseases and hard-to-treat tumours using AI-driven immunotherapies. Nuno discusses the importance of developing proprietary AI models for healthcare, the challenges of data privacy, and the necessity of curating high-quality data. The conversation highlights Portugal's potential as a biotech hub, emphasising the need for talent retention, ecosystem development, and international collaboration to drive innovation in the life sciences sector.
Nuno Prego Ramos is the founder and CEO of Valvian, a Portuguese biotech company launched in January 2024 and announced at the East Coast Grand Investors Conference by Johnson & Johnson Innovation. With a law degree from the University of Lisbon further pursuing a Masters and Ph.D. in Biochemistry and immuno-oncology from Lisbon University, Nuno transitioned from a career in pharmaceuticals to focus on biotechnology. He founded CellmAbs in 2019, developing promising cancer therapies based on humanized monoclonal antibodies. Following the sale of these molecules to BioNTech in January 2024, he established Valvian, aiming to revolutionize cancer and longevity therapies through AI-driven research and to position Portugal as a global biotech leader.
Contacts | Contactos:
CruzamentoPodcast.com
cruzamentopodcast@gmail.com
LinkedIN: Cruzamento
Twitter: @cruzamentofm
Facebook: @podcastcruzamento
Instagram: @cruzamentopodcast
YouTube: Podcast Cruzamento
Episode edited by João Cunha Studios
Podcast Cruzamento
🇵🇹 O Podcast onde os temas da Tecnologia e Saúde se cruzam para criar um espaço de debate aberto e inovador, através de entrevistas descontraídas, mas com conteúdos importantes e atuais. Ambicionamos que este podcast sirva como fonte de inovação e de criatividade para os nossos ouvintes.
🇺🇸 🇬🇧 The Cruzamento Podcast is where Technology and Health intersect to create an open and innovative debate, through relevant, current and informal interviews with recognised thought leaders. Our ambition is that this podcast becomes a source of innovation and creativity for all our listeners.
